Publications
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.
Proceedings of the National Academy of Sciences, Volume 104, No. 24, June 12, 2007.
Read ArticleNovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
European Journal of Cancer, Volume 48, No. 12, 2012.
Read ArticleDelayed response and survival from NovoTTF-100A in recurrent GBM.
Medical Oncology, Volume 3, No. 338, January 2013.
Read ArticleResponse assessment of NovoTTF-100A vs best physician’s choice of chemotherapy in recurrent glioblastoma.
Cancer Medicine, Volume 3, No. 3, 2014.
Read ArticleCharacterization and management of dermatologic adverse events with the NovoTTF-100A system, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma.
Seminars in Oncology, Volume 41, S1 – S14, June, 2014.
Read ArticlePost hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician’s choice chemotherapy.
Seminars in Oncology, Volume 41, S25 – S34, October, 2014.
Read ArticleResponse patterns of recurrent glioblastomas treated With Tumor Treating Fields.
Seminars in Oncology, Volume 41, S14 – S24, October, 2014.
Read ArticleClinical practice experience with NovoTTF-100A™ system for glioblastoma: the Patient Registry Dataset (PRiDe).
Seminars in Oncology, Volume 41, S4 – S13, October, 2014.
Read Article